Role of neck ultrasound during follow-up care of head and neck squamous cell carcinomas

被引:8
|
作者
Park, Jonas J-H [1 ]
Emmerling, Oliver [1 ]
Westhofen, Martin [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Otolaryngol & Head & Neck Surg, D-52074 Aachen, Germany
关键词
Recurrence rate; salvage surgery; REGIONAL RECURRENCE; SALVAGE TREATMENT; SURGICAL SALVAGE; CANCER; DEPRESSION; RADIOTHERAPY; SONOGRAPHY; DISSECTION; SURGERY; FEAR;
D O I
10.3109/00016489.2011.636377
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusion: No impact of neck ultrasound on the detection rate of neck recurrences of head and neck squamous cell carcinomas ( HNSCCs) was seen. The outcome of salvage therapy was not influenced by close neck ultrasound monitoring during follow-up. Tendencies of earlier detection of neck recurrences were noticed. Objectives: Neck ultrasound is more feasible for frequent application than computed tomography, while having comparable sensitivity and specificity in detecting neck metastasis. Before this study the effect of neck ultrasound on salvage therapy of neck recurrences when used in short defined intervals during follow-up was unknown. Methods: A total of 140 patients with primarily surgically treated HNSCC were enrolled in a follow-up program with defined close time intervals. Neck ultrasound was applied during every follow-up visit. Recurrence rate, survival rate, and outcome of salvage therapy were determined. Results: Overall recurrences occurred in 35.0% of patients. Local, regional, and distant recurrences were found in 11.4%, 7.9%, and 15.7%. Hypopharyngeal carcinoma and advanced staged tumor showed highest recurrence rates. In all, 24.5% of all recurrences were treated successfully by salvage therapy. Resection of local, regional, and distant recurrences resulted in 3-year survival rates of 43.8%, 36.4%, and 4.5%. The outcome of secondary therapy worsened with advancing initial primary tumor stage.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 50 条
  • [1] Ultrasound in patients with treated head and neck carcinomas A retrospective analysis for effectiveness of follow-up care
    Jiang, Hongying
    Tan, Qiling
    He, Fawei
    Yang, Wei
    Liu, Jifeng
    Zhou, Fang
    Zhang, Mingxia
    MEDICINE, 2021, 100 (16) : E25496
  • [2] Follow-up ultrasound of head and neck cancer
    Kuenzel, J.
    Bozzato, A.
    Strieth, S.
    HNO, 2017, 65 (11) : 939 - 952
  • [3] Head and neck squamous cell carcinoma: a stratified follow-up program
    De Felice, Francesca
    Lei, Mary
    Oakley, Richard
    Lyons, Andrew
    Fry, Alastair
    Jeannon, Jean-Pierre
    Ricard, Simo
    Urbano, Teresa Guerrero
    ORAL ONCOLOGY, 2021, 118
  • [4] Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck
    Kuropkat, C
    Lippert, BM
    Werner, JA
    ONCOLOGY, 2002, 63 (03) : 280 - 285
  • [5] FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas
    Conessa, C
    Hervé, S
    Foehrenbach, H
    Poncet, JL
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2004, 113 (08): : 628 - 635
  • [6] Role of VEGF in Head and Neck Squamous Cell Carcinomas
    Ghias, Kulsoom
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2014, 4 (04): : 163 - 164
  • [7] The role of NANOG in Head and Neck Squamous Cell Carcinomas
    Pedregal-Mallo, Daniel
    Menendez, Sofia T.
    Granda-Diaz, Rocio
    Allonca, Eva
    Del-Rio-Ibisate, Nagore
    Menendez, Marta
    Garcia-Pedrero, Juana M.
    Pablo Rodrigo, Juan
    ORAL ONCOLOGY, 2021, 118
  • [8] Squamous cell carcinomas of the head and neck
    Sanderson, RJ
    Ironside, JAD
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7368): : 822 - 827
  • [9] Squamous cell carcinomas of the head and neck
    Demard, F.
    Schneider, M.
    ONCOLOGIE, 2009, 11 (03) : 115 - 115
  • [10] Squamous Cell Carcinoma Antigen in the Follow-up of Patients With Head and Neck Cancer
    Schepens, Emma J. A.
    Al-Mamgani, Abrahim
    Karssemakers, Luc H. E.
    van den Broek, Daan
    van den Brekel, Michiel. W. M.
    Lopez-Yurda, Marta
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (02) : 422 - 430